双重gRNA的CRISPR/Cas9系统协同抑制B型肝炎病毒复制
Ling Fei1, ShuangShuang Sun2, Qunling Yang1
1Department of Liver Disease, Shanghai Public Health Clinical Center, Fudan University, 201508 Shanghai, China.
Discovery medicine
|June 26, 2024
概括
双导引RNA (gRNA) CRISPR/Cas9疗法在抑制乙型肝炎病毒 (HBV) 复制和促进病毒清除方面显示出增强的疗效. 这种基因编辑方法为慢性HBV感染患者的功能治疗提供了潜在的潜力.
科学领域:
- 分子生物学分子生物学
- 基因编辑技术的技术
- 病毒学 病毒学
背景情况:
- 乙型肝炎病毒 (HBV) 感染是一个全球性的健康问题,治疗治疗方法有限.
- 目前的抗病毒疗法无法消除HBV,使其成为新型干预的目标.
- 聚类正规间隔短平行体重复 (CRISPR) /Cas9基因编辑正在向临床应用迈进.
研究的目的:
- 为了提高CRISPR/Cas9在抑制HBV复制的疗效.
- 降低乙型肝炎表面抗原 (HBsAg) 和乙型肝炎e抗原 (HBeAg) 的水平.
- 为了消除共价封闭圆形DNA (cccDNA) 的潜在功能治愈.
主要方法:
- 采用双导向RNA (gRNA) 策略来优化CRISPR/Cas9的抗HBV活性.
- 评估了多个针对不同保存的HBV区域的gRNA.
- 三种有效的gRNAs (10,4和21) 被选择用于联合应用.
主要成果:
- 与gRNA-4或gRNA-21同时应用gRNA-10显著增强了细胞系和感染模型中的HBV复制的抑制.
- 双重gRNA策略导致HBsAg,HBeAg和ccDNA水平的较大降低.
- 与单个gRNA使用相比,双gRNA方法显示出更明显地促进HBsAg清除.
结论:
- 具有双重gRNA的CRISPR/Cas9系统在抑制HBV复制方面非常有效.
- 这种基因编辑策略促进HBsAg清除,表明HBV功能治愈的潜力.
- 双 gRNA CRISPR/Cas9 呈现了一种有前途的新型治疗方法,用于HBV感染.
更多相关视频
10:42A Protocol for the Production of Integrase-deficient Lentiviral Vectors for CRISPR/Cas9-mediated Gene Knockout in Dividing Cells
Published on: December 12, 2017
15.2K
13:47Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
Published on: March 29, 2019
9.5K
相关概念视频
CRISPR
50.5K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
50.5K
CRISPR and crRNAs
17.0K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.0K
